TY - JOUR
T1 - Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons
AU - Currais, Antonio
AU - Kato, Kiyoko
AU - Canuet, Leonides
AU - Ishii, Ryouhei
AU - Tanaka, Toshihisa
AU - Takeda, Masatoshi
AU - Soriano, Salvador
N1 - Funding Information:
Acknowledgments This work was funded by the Alzheimer’s Research Trust (ART/PhD2005/1 to SS), Fundação para a Ciência e Tecnologia (SFRH/BD/21406/2005 to AC), and Japan Society for the Promotion of Science (ID no. PE08565 to AC). We are grateful to Dr Peter Davies for the PHF-1 and Tau-1 antibodies and we thank Dr. Christopher Towlson and Dr. Ana Nunes for technical help.
PY - 2011/3
Y1 - 2011/3
N2 - Neuronal cell cycle reentry, which is associated with aberrant tau phosphorylation, is thought to be a mechanism of neurodegeneration in AD. Caffeine is a neuroprotective drug known to inhibit the cell cycle, suggesting that its neuroprotective nature may rely, at least in part, on preventing tau abnormalities secondary to its inhibitory effect on neuronal cell cycle-related pathways. Accordingly, we have explored in the present study the impact of caffeine on cell cycle-linked parameters and tau phosphorylation patterns in an attempt to identify molecular clues to its neuroprotective effect. We show that caffeine blocks the cell cycle at G1 phase in neuroblastoma cells and leads to a decrease in tau phosphorylation; similarly, exposure of postmitotic neurons to caffeine led to changes in tau phosphorylation concomitantly with downregulation of Akt signaling. Taken together, our results show a unique impact of caffeine on tau phosphorylation and warrant further investigation to address whether caffeine may help prevent neuronal death by preventing tau abnormalities secondary to aberrant entry into the cell cycle.
AB - Neuronal cell cycle reentry, which is associated with aberrant tau phosphorylation, is thought to be a mechanism of neurodegeneration in AD. Caffeine is a neuroprotective drug known to inhibit the cell cycle, suggesting that its neuroprotective nature may rely, at least in part, on preventing tau abnormalities secondary to its inhibitory effect on neuronal cell cycle-related pathways. Accordingly, we have explored in the present study the impact of caffeine on cell cycle-linked parameters and tau phosphorylation patterns in an attempt to identify molecular clues to its neuroprotective effect. We show that caffeine blocks the cell cycle at G1 phase in neuroblastoma cells and leads to a decrease in tau phosphorylation; similarly, exposure of postmitotic neurons to caffeine led to changes in tau phosphorylation concomitantly with downregulation of Akt signaling. Taken together, our results show a unique impact of caffeine on tau phosphorylation and warrant further investigation to address whether caffeine may help prevent neuronal death by preventing tau abnormalities secondary to aberrant entry into the cell cycle.
KW - Akt
KW - Alzheimer's
KW - Caffeine
KW - Cell cycle
KW - Neurodegeneration
KW - Tau
UR - http://www.scopus.com/inward/record.url?scp=79955789404&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955789404&partnerID=8YFLogxK
U2 - 10.1007/s12031-010-9444-8
DO - 10.1007/s12031-010-9444-8
M3 - Article
C2 - 20838929
SN - 0895-8696
VL - 43
SP - 326
EP - 332
JO - Journal of Molecular Neuroscience
JF - Journal of Molecular Neuroscience
IS - 3
ER -